Trump Announces New Tariffs on Generic Drugs to Take Effect in 2028 – As It Happened

Donald Trump’s latest move to impose tariffs on generic drugs made overseas has left many wondering what’s behind this sudden about-face. The announcement, which will see a 100% tariff slapped on these imports starting in 2028, is the latest iteration of Trump’s protectionist policies aimed at coercing foreign companies into building plants in the United States.

The fact that these tariffs won’t kick in until 2028 suggests that Trump’s primary goal isn’t so much about generating revenue or safeguarding domestic industries but rather about exerting influence over the global pharmaceutical market. By holding out the threat of a massive tariff hike, he aims to cajole foreign companies into building new facilities within American borders.

This move raises questions about America’s commitment to international cooperation. The US has long touted its role as a champion of free trade and a beacon of global leadership. Yet, under Trump’s watch, America seems increasingly isolated on the world stage – from abandoning the Paris Climate Accord to pulling out of the Iran nuclear deal.

Other countries have successfully navigated these challenges without resorting to protectionist measures. Japan and South Korea, for instance, have invested heavily in their own domestic industries while maintaining open trade policies with their global partners. Why can’t America follow suit?

As tensions simmer between Washington and Beijing, Trump’s tariffs on generic drugs risk further polarizing the global economy – and undermining America’s very own sovereignty.

Across the Atlantic, another story is unfolding that highlights the tension between national sovereignty and international cooperation. New York Mayor Zohran Mamdani has called for the arrest of Israeli Prime Minister Benjamin Netanyahu on war crimes charges, citing his administration’s review of applicable law. This development has sparked a heated debate about America’s relationship with the International Criminal Court (ICC) – and its role in upholding global norms.

The US has maintained that it will not abide by ICC rulings or recognize its jurisdiction over American citizens. Trump himself has rejected the idea, claiming that “Benjamin Netanyahu will not be arrested, in any way, shape, or form, while in the United States of America.” Yet, Mamdani’s stance reflects a growing recognition among world leaders of the need for collective action to address global atrocities.

Unlike 125 other countries, the US has chosen not to ratify the Rome Statute – which established the ICC and set out its mandate. This decision has left America isolated on the international stage. The arrest of Augusto Pinochet in 1998 highlighted the role of international law in holding leaders accountable for their actions – even if they are sitting heads of state.

In a separate development, reports have emerged that Donald Trump has approved a deal to provide nuclear enrichment infrastructure to Saudi Arabia. The agreement, which could be worth tens of billions of dollars over its 30-year lifespan, marks a significant shift in the global balance of power.

By providing Saudi Arabia with the means to enrich uranium, America is essentially backing a major player in the Middle East – and embarking on a new era of great-power politics. This move raises questions about Washington’s commitment to non-proliferation efforts and its willingness to push back against Iran’s nuclear ambitions.

For years, Trump has railed against Iran’s supposed threat to regional security. Yet, by providing Saudi Arabia with the means to enrich uranium, America seems to be acknowledging that other countries in the region – namely, Saudi Arabia – may also need or want to develop their own nuclear capabilities.

As tensions between Washington and Tehran continue to simmer, Trump’s nuclear deal with Saudi Arabia risks further destabilizing an already volatile region. What are the implications for regional security? And what does this say about America’s priorities in the Middle East?

Trump’s tariffs on generic drugs and nuclear deal with Saudi Arabia represent two sides of the same coin – an attempt to exert control over global markets and maintain influence in critical regions. Yet, these moves risk further polarizing the world stage and undermining America’s own sovereignty.

As we navigate this complex web of national sovereignty and international cooperation, it’s essential that we remember the lessons of history. The answer lies not just in Washington but also in our global partnerships – and our willingness to adapt to an ever-changing world.

The choice is ours: will we be remembered as champions of global leadership or as protagonists of protectionism? The stakes have never been higher.